US Patent 10894039 Amlodipine formulations
Patent 10894039 was granted and assigned to Silvergate Pharmaceuticals, Inc. on January, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 20, 2020
Date of Patent
January 19, 2021
Patent Applicant
Patent Application Number
16853380
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10894039 Amlodipine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
